Alzheimer Disease
Roche Licenses Alzheimer compounds from Memory Pharmaceuticals
Published in Pain and Central Nervous System Week, October 7th, 2002
In addition, Roche and Memory will develop compounds within the same drug class for other indications, such as depression. The first drug candidate represents a novel approach and shows promising features compared with existing therapies for Alzheimer's disease. It is scheduled to enter human clinical trials in the near future.
Memory's compounds will complement Roche's neurology portfolio, and the collaboration will also broaden efforts in discovery of drug treatments for psychiatric...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
More Articles from Pain and Central Nervous System Week
- Amyotrophic Lateral Sclerosis
Athleticism and body weight tied to ALS and other motor neuron diseases - Myopathy
Identification of chemokines and cytokines offers new hope for patients - Autism
Major breakthrough in treatment - Bipolar Disorder
Researcher studies causes, treatment of bipolar disease coupled with drug abuse - Depression
Study results offer new hope for people with manic depression - Gulf War Syndrome
Poor health of veterans not related to post-traumatic stress disorder - More from this issue of Pain and Central Nervous System Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
